Hmdb loader
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2006-08-13 22:15:19 UTC
Update Date2022-03-07 02:49:21 UTC
HMDB IDHMDB0004611
Secondary Accession Numbers
  • HMDB04611
Metabolite Identification
Common Name7a-Hydroxydehydroepiandrosterone
Description7a-Hydroxydehydroepiandrosterone is a major metabolite of dehydroepiandrosterone (DHEA), which is is 7alpha-hydroxylated by the cytochrome P450 7B1 (EC 1.14.13.100, 25-hydroxycholesterol 7alpha-hydroxylase, CYP7B1) in the human brain and liver microsomes. Exposure to the proinflammatory cytokines TNFalpha, IL-1alpha, IL-1beta, and IL-17 increases CYP7B activity in synovial tissue. Increased CYP7B activity leads to higher levels of the DHEA metabolite 7alpha-OH-DHEA in synovial fluid, which may contribute to the maintenance of the chronic inflammation observed in rheumatoid arthritis patients. The glucocorticoid dhydrocorticosterone inhibits the conversion of DHEA to 7a-Hydroxydehydroepiandrosterone. The total levels of 7a-Hydroxydehydroepiandrosterone are increased in serum of patients with Alzheimer's disease. (PMID: 17467270 , 15751070 , 12667489 , 9520908 ).
Structure
Data?1582752309
Synonyms
ValueSource
(3beta,7alpha)-3,7-Dihydroxyandrost-5-en-17-oneChEBI
3beta,7alpha-Dihydroxy-5-androstene-17-oneChEBI
3beta,7alpha-Dihydroxyandrost-5-en-17-oneChEBI
7alpha-Hydroxy-dheaChEBI
7alpha-OH-DHEAChEBI
(3b,7a)-3,7-Dihydroxyandrost-5-en-17-oneGenerator
(3Β,7α)-3,7-dihydroxyandrost-5-en-17-oneGenerator
3b,7a-Dihydroxy-5-androstene-17-oneGenerator
3Β,7α-dihydroxy-5-androstene-17-oneGenerator
3b,7a-Dihydroxyandrost-5-en-17-oneGenerator
3Β,7α-dihydroxyandrost-5-en-17-oneGenerator
7a-Hydroxy-dheaGenerator
7Α-hydroxy-dheaGenerator
7a-OH-DHEAGenerator
7Α-OH-dheaGenerator
7-HydroxydehydroepiandrosteroneMeSH
7beta-HydroxydehydroepiandrosteroneMeSH
7-Hydroxydehydroepiandrosterone, (3beta)-isomerMeSH
7beta-OH-DHEAMeSH
7 alpha-HydroxydehydroepiandrosteroneMeSH
7-Hydroxydehydroepiandrosterone, (3beta,7beta)-isomerMeSH
(-)-7a-HydroxydehydroepiandrosteroneHMDB
(3b,7a)-3,7-Dihydroxy-androst-5-en-17-oneHMDB
3b,7a-Dihydroxy-5-androsten-17-oneHMDB
3b,7a-Dihydroxy-androst-5-en-17-oneHMDB
7-a-OH-DHEAHMDB
7-alpha-OH-DHEAHMDB
7a-HydroxydehydroisoandrosteroneHMDB
Chemical FormulaC19H28O3
Average Molecular Weight304.4238
Monoisotopic Molecular Weight304.203844762
IUPAC Name(1S,2R,5S,9S,10R,11S,15S)-5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-14-one
Traditional Name7β-oh-dhea
CAS Registry Number53-00-9
SMILES
[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@H](O)C=C2C[C@@H](O)CC[C@]12C
InChI Identifier
InChI=1S/C19H28O3/c1-18-7-5-12(20)9-11(18)10-15(21)17-13-3-4-16(22)19(13,2)8-6-14(17)18/h10,12-15,17,20-21H,3-9H2,1-2H3/t12-,13-,14-,15+,17-,18-,19-/m0/s1
InChI KeyOLPSAOWBSPXZEA-JIEICEMKSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as androgens and derivatives. These are 3-hydroxylated C19 steroid hormones. They are known to favor the development of masculine characteristics. They also show profound effects on scalp and body hair in humans.
KingdomOrganic compounds
Super ClassLipids and lipid-like molecules
ClassSteroids and steroid derivatives
Sub ClassAndrostane steroids
Direct ParentAndrogens and derivatives
Alternative Parents
Substituents
  • Androgen-skeleton
  • 3-hydroxy-delta-5-steroid
  • 3-hydroxysteroid
  • 7-hydroxysteroid
  • 3-beta-hydroxysteroid
  • 3-beta-hydroxy-delta-5-steroid
  • Oxosteroid
  • 17-oxosteroid
  • Hydroxysteroid
  • Delta-5-steroid
  • Cyclic alcohol
  • Secondary alcohol
  • Ketone
  • Organic oxygen compound
  • Organooxygen compound
  • Carbonyl group
  • Hydrocarbon derivative
  • Alcohol
  • Organic oxide
  • Aliphatic homopolycyclic compound
Molecular FrameworkAliphatic homopolycyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
Process
Role
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting Point182 - 183 °CNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.13 g/LALOGPS
logP1.84ALOGPS
logP2.21ChemAxon
logS-3.4ALOGPS
pKa (Strongest Acidic)18.2ChemAxon
pKa (Strongest Basic)-0.81ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area57.53 ŲChemAxon
Rotatable Bond Count0ChemAxon
Refractivity86.1 m³·mol⁻¹ChemAxon
Polarizability34.78 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+169.63131661259
DarkChem[M-H]-166.20531661259
DeepCCS[M-2H]-206.33430932474
DeepCCS[M+Na]+181.13330932474
AllCCS[M+H]+177.932859911
AllCCS[M+H-H2O]+174.832859911
AllCCS[M+NH4]+180.732859911
AllCCS[M+Na]+181.532859911
AllCCS[M-H]-180.532859911
AllCCS[M+Na-2H]-180.632859911
AllCCS[M+HCOO]-180.832859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022.5.07 minutes32390414
Predicted by Siyang on May 30, 202211.9027 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20221.35 minutes32390414
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid2365.0 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid225.9 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid173.7 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid170.9 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid274.9 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid464.7 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid494.9 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)119.0 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid985.7 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid409.0 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid1294.7 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid291.7 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid365.3 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate385.3 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA340.0 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water41.0 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
7a-Hydroxydehydroepiandrosterone[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@H](O)C=C2C[C@@H](O)CC[C@]12C2704.9Standard polar33892256
7a-Hydroxydehydroepiandrosterone[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@H](O)C=C2C[C@@H](O)CC[C@]12C2693.3Standard non polar33892256
7a-Hydroxydehydroepiandrosterone[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@H](O)C=C2C[C@@H](O)CC[C@]12C2823.8Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
7a-Hydroxydehydroepiandrosterone,1TMS,isomer #1C[C@]12CC[C@H]3[C@@H]([C@H](O[Si](C)(C)C)C=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CCC2=O2735.6Semi standard non polar33892256
7a-Hydroxydehydroepiandrosterone,1TMS,isomer #2C[C@]12CC[C@H]3[C@@H]([C@H](O)C=C4C[C@@H](O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CCC2=O2723.8Semi standard non polar33892256
7a-Hydroxydehydroepiandrosterone,1TMS,isomer #3C[C@]12CC[C@H]3[C@@H]([C@H](O)C=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2O[Si](C)(C)C2702.2Semi standard non polar33892256
7a-Hydroxydehydroepiandrosterone,2TMS,isomer #1C[C@]12CC[C@H]3[C@@H]([C@H](O[Si](C)(C)C)C=C4C[C@@H](O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CCC2=O2689.5Semi standard non polar33892256
7a-Hydroxydehydroepiandrosterone,2TMS,isomer #2C[C@]12CC[C@H]3[C@@H]([C@H](O[Si](C)(C)C)C=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2O[Si](C)(C)C2731.3Semi standard non polar33892256
7a-Hydroxydehydroepiandrosterone,2TMS,isomer #3C[C@]12CC[C@H]3[C@@H]([C@H](O)C=C4C[C@@H](O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CC=C2O[Si](C)(C)C2717.5Semi standard non polar33892256
7a-Hydroxydehydroepiandrosterone,3TMS,isomer #1C[C@]12CC[C@H]3[C@@H]([C@H](O[Si](C)(C)C)C=C4C[C@@H](O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CC=C2O[Si](C)(C)C2673.4Semi standard non polar33892256
7a-Hydroxydehydroepiandrosterone,3TMS,isomer #1C[C@]12CC[C@H]3[C@@H]([C@H](O[Si](C)(C)C)C=C4C[C@@H](O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CC=C2O[Si](C)(C)C2714.7Standard non polar33892256
7a-Hydroxydehydroepiandrosterone,3TMS,isomer #1C[C@]12CC[C@H]3[C@@H]([C@H](O[Si](C)(C)C)C=C4C[C@@H](O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CC=C2O[Si](C)(C)C2967.2Standard polar33892256
7a-Hydroxydehydroepiandrosterone,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)O[C@@H]1C=C2C[C@@H](O)CC[C@]2(C)[C@H]2CC[C@]3(C)C(=O)CC[C@H]3[C@H]122993.6Semi standard non polar33892256
7a-Hydroxydehydroepiandrosterone,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)O[C@H]1CC[C@@]2(C)C(=C[C@@H](O)[C@H]3[C@@H]4CCC(=O)[C@@]4(C)CC[C@@H]32)C12993.5Semi standard non polar33892256
7a-Hydroxydehydroepiandrosterone,1TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC1=CC[C@H]2[C@@H]3[C@H](O)C=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C2998.8Semi standard non polar33892256
7a-Hydroxydehydroepiandrosterone,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)O[C@H]1CC[C@@]2(C)C(=C[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]3[C@@H]4CCC(=O)[C@@]4(C)CC[C@@H]32)C13211.5Semi standard non polar33892256
7a-Hydroxydehydroepiandrosterone,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC1=CC[C@H]2[C@@H]3[C@H](O[Si](C)(C)C(C)(C)C)C=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C3295.9Semi standard non polar33892256
7a-Hydroxydehydroepiandrosterone,2TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC1=CC[C@H]2[C@@H]3[C@H](O)C=C4C[C@@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C3252.4Semi standard non polar33892256
7a-Hydroxydehydroepiandrosterone,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC1=CC[C@H]2[C@@H]3[C@H](O[Si](C)(C)C(C)(C)C)C=C4C[C@@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C3397.4Semi standard non polar33892256
7a-Hydroxydehydroepiandrosterone,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC1=CC[C@H]2[C@@H]3[C@H](O[Si](C)(C)C(C)(C)C)C=C4C[C@@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C3107.1Standard non polar33892256
7a-Hydroxydehydroepiandrosterone,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC1=CC[C@H]2[C@@H]3[C@H](O[Si](C)(C)C(C)(C)C)C=C4C[C@@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C3265.5Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - 7a-Hydroxydehydroepiandrosterone GC-MS (Non-derivatized) - 70eV, Positivesplash10-03g0-0390000000-5b84fc74cc8c3d885c1b2017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 7a-Hydroxydehydroepiandrosterone GC-MS (2 TMS) - 70eV, Positivesplash10-003r-5204900000-bdb069dd8202b45f9ea32017-10-06Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 7a-Hydroxydehydroepiandrosterone GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 7a-Hydroxydehydroepiandrosterone 10V, Positive-QTOFsplash10-00kr-0092000000-003d307a3c381597e38b2017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 7a-Hydroxydehydroepiandrosterone 20V, Positive-QTOFsplash10-0ap0-0190000000-7563041720b7687053892017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 7a-Hydroxydehydroepiandrosterone 40V, Positive-QTOFsplash10-0a6u-3190000000-8012f9fad41969d73d462017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 7a-Hydroxydehydroepiandrosterone 10V, Negative-QTOFsplash10-0udi-0049000000-3459db2d82d83321802f2017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 7a-Hydroxydehydroepiandrosterone 20V, Negative-QTOFsplash10-0udr-0098000000-6a1aaf578c3c1719798a2017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 7a-Hydroxydehydroepiandrosterone 40V, Negative-QTOFsplash10-059f-2090000000-85d4a8001358a115f59b2017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 7a-Hydroxydehydroepiandrosterone 10V, Negative-QTOFsplash10-0udi-0009000000-93986d59045cc7fce5512021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 7a-Hydroxydehydroepiandrosterone 20V, Negative-QTOFsplash10-0udi-0019000000-8b3060136e49afe5a3362021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 7a-Hydroxydehydroepiandrosterone 40V, Negative-QTOFsplash10-0uy0-0093000000-e42b11a1c3c059294db32021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 7a-Hydroxydehydroepiandrosterone 10V, Positive-QTOFsplash10-0a4i-0069000000-61a09d88b13611d21a892021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 7a-Hydroxydehydroepiandrosterone 20V, Positive-QTOFsplash10-0670-1981000000-b0f1410f207bdaec9fa12021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 7a-Hydroxydehydroepiandrosterone 40V, Positive-QTOFsplash10-05dl-3910000000-4b2efd9d887548375fc02021-09-25Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Extracellular
  • Membrane
Biospecimen LocationsNot Available
Tissue LocationsNot Available
Pathways
Normal Concentrations
Not Available
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDFDB023382
KNApSAcK IDNot Available
Chemspider ID58963
KEGG Compound IDC18045
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia Link7alpha-Hydroxy-DHEA
METLIN IDNot Available
PubChem Compound65517
PDB IDNot Available
ChEBI ID712194
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceIshidate, Morizo; Okada, Masashi. Steroids. (1963), 2 pp. JP 38023170 19631031 Showa. CAN 60:12972 AN 1964:12972
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Hennebert O, Chalbot S, Alran S, Morfin R: Dehydroepiandrosterone 7alpha-hydroxylation in human tissues: possible interference with type 1 11beta-hydroxysteroid dehydrogenase-mediated processes. J Steroid Biochem Mol Biol. 2007 May;104(3-5):326-33. Epub 2007 Mar 24. [PubMed:17467270 ]
  2. Robinzon B, Michael KK, Ripp SL, Winters SJ, Prough RA: Glucocorticoids inhibit interconversion of 7-hydroxy and 7-oxo metabolites of dehydroepiandrosterone: a role for 11beta-hydroxysteroid dehydrogenases? Arch Biochem Biophys. 2003 Apr 15;412(2):251-8. [PubMed:12667489 ]
  3. Dulos J, van der Vleuten MA, Kavelaars A, Heijnen CJ, Boots AM: CYP7B expression and activity in fibroblast-like synoviocytes from patients with rheumatoid arthritis: regulation by proinflammatory cytokines. Arthritis Rheum. 2005 Mar;52(3):770-8. [PubMed:15751070 ]
  4. Attal-Khemis S, Dalmeyda V, Michot JL, Roudier M, Morfin R: Increased total 7 alpha-hydroxy-dehydroepiandrosterone in serum of patients with Alzheimer's disease. J Gerontol A Biol Sci Med Sci. 1998 Mar;53(2):B125-32. [PubMed:9520908 ]

Enzymes

General function:
Involved in monooxygenase activity
Specific function:
Catalyzes a rate-limiting step in cholesterol catabolism and bile acid biosynthesis by introducing a hydrophilic moiety at position 7 of cholesterol. Important for cholesterol homeostasis.
Gene Name:
CYP7A1
Uniprot ID:
P22680
Molecular weight:
57660.155
Reactions
Dehydroepiandrosterone + Oxygen + NADPH + Hydrogen Ion → 7a-Hydroxydehydroepiandrosterone + NADP + Waterdetails
General function:
Involved in oxidoreductase activity
Specific function:
Catalyzes reversibly the conversion of cortisol to the inactive metabolite cortisone. Catalyzes reversibly the conversion of 7-ketocholesterol to 7-beta-hydroxycholesterol. In intact cells, the reaction runs only in one direction, from 7-ketocholesterol to 7-beta-hydroxycholesterol (By similarity).
Gene Name:
HSD11B1
Uniprot ID:
P28845
Molecular weight:
32400.665
References
  1. Hennebert O, Chalbot S, Alran S, Morfin R: Dehydroepiandrosterone 7alpha-hydroxylation in human tissues: possible interference with type 1 11beta-hydroxysteroid dehydrogenase-mediated processes. J Steroid Biochem Mol Biol. 2007 May;104(3-5):326-33. Epub 2007 Mar 24. [PubMed:17467270 ]
General function:
Involved in monooxygenase activity
Specific function:
Not Available
Gene Name:
CYP7B1
Uniprot ID:
O75881
Molecular weight:
58255.325
References
  1. Hennebert O, Chalbot S, Alran S, Morfin R: Dehydroepiandrosterone 7alpha-hydroxylation in human tissues: possible interference with type 1 11beta-hydroxysteroid dehydrogenase-mediated processes. J Steroid Biochem Mol Biol. 2007 May;104(3-5):326-33. Epub 2007 Mar 24. [PubMed:17467270 ]